Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06822231 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project

Study acronym: Fit4MR-AcMND
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Aug 2026 → Oct 2026
See other at-risk trials from Istituti Clinici Scientifici Maugeri SpA

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 2026 to Oct 2026
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 8 of 9 entries
  2. Primary completion date: Feb 2026 to Aug 2026
    • Study completion date: Feb 2026 to Nov 2026
    v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2025 to May 28, 2025
    • Site details revised at 8 of 8 sites
    v4
  4. Start date: Feb 2025 to May 2025v3
  5. Secondary endpoints revised (9)v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is determine if a high-tech rehabilitation circuit is more effective than usual rehabilitation methods in improving functional outcome, particularly balance control, for patients with acute neuromuscolar diseases. The main question it aims to answer is: Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, more effective than traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with acute neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
Trial Details
NCT Number NCT06822231
Lead Sponsor Istituti Clinici Scientifici Maugeri SpA
Collaborators: Azienda Ospedaliero-Universitaria di Modena, Fondazione Don Carlo Gnocchi ETS, Ospedale Policlinico San Martino
Conditions
(from sponsor)		 Critical Illness Myopathy, Guillain Barré Syndrome, Critical Illness Polyneuromyopathy (CIPNM)
Related terms Guillain-Barre Syndrome
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov